LDR (Austin, Texas) is moving forward in its bid to gain approval for the commercial sale of its Mobi-C cervical artificial disc in the U.S. The firm recently reported the submission of its two level Mobi-C cervical artificial disc PMA to the FDA and said that it is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up. (Medical Device Daily) Read More
